Sotac Pharmaceuticals Limited (NSE:SOTAC)
India · Delayed Price · Currency is INR 90.05
0.00 (0.00%)
Oct 1, 2026, 2:34 PM IST
Sotac Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Sotac Pharmaceuticals had annual revenue of 1.01B INR with 1.33% growth. Sotac Pharmaceuticals had revenue of 642.47M in the half year ending March 31, 2026, with 22.87% growth. That makes Sotac Pharmaceuticals the world's 37,107th largest company by revenue and 3,179th in India.
Revenue
1.01B
Revenue Growth
+1.33%
P/S Ratio
0.98
Revenue / Employee
18.41M
Employees
55
Market Cap
995.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.01B | 13.28M | 1.33% |
| Mar 31, 2025 | 999.29M | -39.51M | -3.80% |
| Mar 31, 2024 | 1.04B | 263.97M | 34.07% |
| Mar 31, 2023 | 774.83M | 43.32M | 5.92% |
| Mar 31, 2022 | 731.52M | 243.09M | 49.77% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 8.54B |
| Accent Microcell | 3.50B |
| Infinium Pharmachem | 1.90B |
| Zenith Drugs | 1.71B |
| Quest Laboratories | 1.12B |
| Sunrest Lifescience | 708.33M |
| Vilin Bio Med | 422.63M |
| Medicamen Organics | 226.30M |